Engineering multiple U7snRNA constructs to induce single and multiexon-skipping for Duchenne muscular dystrophy

Area of Science:

• Genetics
• Molecular Biology
• Biotechnology

Background:

• Duchenne muscular dystrophy (DMD) is a fatal genetic disorder caused by mutations in the dystrophin gene.
• Current treatments face challenges in personalized medicine due to diverse patient mutations.
• A significant portion of DMD cases involve deletions in a specific 'hot-spot' region of the dystrophin gene.

Purpose of the Study:

• To develop a versatile exon-skipping strategy for Duchenne muscular dystrophy.
• To create U7 small-nuclear RNA (snRNA) constructs targeting a hot-spot region of the dystrophin gene.
• To demonstrate the efficacy of multi-exon skipping for potential DMD therapies.

Main Methods:

• Development of 11 distinct U7 snRNA constructs to deliver antisense sequences.
• Design of constructs to mask splicing elements in exons 45 to 55 of the dystrophin gene.
• In vitro testing in Duchenne muscular dystrophy patient myoblasts and in vivo testing in human DMD mice.

Main Results:

• Demonstrated efficient exon skipping in both in vitro and in vivo models.
• Showcased the ability to combine multiple U7 snRNA constructs into a single vector.
• Achieved multi-exon skipping of at least three exons using the combined vector approach.

Conclusions:

• Adeno-associated viral (AAV) vectors encoding multiple U7 snRNAs are effective for multi-exon skipping.
• This approach provides a promising strategy for the clinical treatment of Duchenne muscular dystrophy.
• The developed technology offers a potential pathway towards personalized medicine for DMD patients.